Dr. Huma Qamar's Innovating Impact on Healthcare

As a committed and distinguished healthcare figure, Dr. Huma Qamar is known for her commitment to innovation and excellence. Dr. Huma is the Chief Scientific Officer and Head of Research and Development at Medicus Pharma. Through these roles and with her natural determination, she continues to make impressive strides in medical innovation. 

With just $100 to her name, Dr. Huma started off on a decade-long journey to change medicine which would lead her from her home country of Pakistan to the United States. 

“Like any other immigrant,” Dr. Huma described, “I knew that the USA was a land of opportunities.” It was here, she said, that putting in hard work could lead her to succeeding in her dreams. 

She saw America as a place where she could carve out her destiny. After graduating from medical school, she seized an excellent clinical research opportunity at Yale University, beginning her illustrious professional journey. 

Her path was not without its challenges. As a single immigrant navigating the healthcare landscape, Dr. Huma had to work five times harder than others. However, she still made significant strides in the scientific community, blending her passion for public health, clinical research, and medicine to benefit the communities of the Greater Philadelphia Area. 

Throughout her career, Dr. Huma has left a memorable mark on prestigious institutions such as Yale, Harvard, and the University of Pennsylvania, as well as outstanding hospitals like Thomas Jefferson University Hospital and The Children's Hospital of Philadelphia. 

Today, Dr. Huma serves as the Chief Scientific Officer and Head of Research and Development at Medicus Pharma. She is deeply engaged in derm-oncology, leading efforts to revolutionize the treatment of basal cell carcinoma. 

"I am currently overseeing the Phase 2 Basal Cell Carcinoma trial utilizing a novel Microneedle array approach to treat the skin cancer with minimum invasion and pain." Dr. Huma mentions. 

Dr. Huma's latest endeavors include cutting-edge gene therapy and artificial intelligence projects. At Ocugen, she has contributed to a new modifier gene therapy clinical development program targeting inherited retinal diseases, Geographic Atrophy, and Stargardt diseases. 

Dr. Huma is looking to explore the field of Artificial Intelligence to broaden her horizons for upcoming projects. She has a vision of introducing AI models in the United States and Gulf countries, recognizing ample opportunities for collaborative efforts to foster scientific innovation worldwide. 

She also aspires to make a lasting impact on the healthcare landscape by assuming a leadership position as a Chief Executive Officer, where she can create a more significant, meaningful impact. 

Dr. Huma advises aspiring medical graduates to adopt a forward-thinking mindset, emphasizing the significance of gaining clinical experience beyond textbook knowledge. 

"My advice, especially to foreign medical graduates (MDs), is to think outside the box and see prospectively how the scientific/clinical research industry will look in the next 5-7 years." Dr. Huma emphasizes.  

As a leader in clinical research and medical innovation, Dr. Huma continues to inspire through her impressive contributions, shaping the future of healthcare for generations to come. 

To learn more about Dr. Huma Qamar's medical journey, click here. 

This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.